Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing
暂无分享,去创建一个
Julian Q. Zhou | S. Kleinstein | Tamara J. Gilbert | R. Barohn | Francois Vigneault | Luan Chen | K. O’Connor | M. Dimachkie | C. Bolen | T. Broering | R. Nowak | P. Stathopoulos | E. Ciafaloni | J. V. Vander Heiden
[1] G. Cutter,et al. Randomized trial of thymectomy in myasthenia gravis. , 2016, Journal of thoracic disease.
[2] E. Santos,et al. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases , 2016, Muscle & nerve.
[3] H. Atkins,et al. Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation. , 2016, JAMA neurology.
[4] Jason A. Vander Heiden,et al. Compromised fidelity of B‐cell tolerance checkpoints in AChR and MuSK myasthenia gravis , 2016, Annals of clinical and translational neurology.
[5] Cornelia L Dekker,et al. Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells , 2016, Nature Communications.
[6] E. Meffre,et al. Rituximab does not reset defective early B cell tolerance checkpoints. , 2016, The Journal of clinical investigation.
[7] Steven H. Kleinstein,et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data , 2015, Bioinform..
[8] Steven H. Kleinstein,et al. The mutation patterns in B-cell immunoglobulin receptors reflect the influence of selection acting at multiple time-scales , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.
[9] A. Cope,et al. Immunoglobulin kappa variable region gene selection during early human B cell development in health and systemic lupus erythematosus. , 2015, Molecular immunology.
[10] Robert K. Colwell,et al. Unveiling the species-rank abundance distribution by generalizing the Good-Turing sample coverage theory. , 2015, Ecology.
[11] G. Yaari,et al. Automated analysis of high-throughput B-cell sequencing data reveals a high frequency of novel immunoglobulin V gene segment alleles , 2015, Proceedings of the National Academy of Sciences.
[12] M. Sirota,et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis , 2014, Science Translational Medicine.
[13] Steven H. Kleinstein,et al. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes , 2014, Science Translational Medicine.
[14] K. Kleopa,et al. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. , 2014, Journal of autoimmunity.
[15] J. Maessen,et al. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. , 2014, Journal of autoimmunity.
[16] S. Berrih-Aknin. Myasthenia Gravis: paradox versus paradigm in autoimmunity. , 2014, Journal of autoimmunity.
[17] Mark M. Davis,et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. , 2014, Cell host & microbe.
[18] E. Eichler,et al. Sequencing of the human IG light chain loci from a hydatidiform mole BAC library reveals locus-specific signatures of genetic diversity , 2014, Genes and Immunity.
[19] David A. Hafler,et al. pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires , 2014, Bioinform..
[20] M. van der Burg,et al. Wiskott–Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans☆ , 2014, Journal of autoimmunity.
[21] D. Koller,et al. High-resolution antibody dynamics of vaccine-induced immune responses , 2014, Proceedings of the National Academy of Sciences.
[22] Steven H. Kleinstein,et al. Models of Somatic Hypermutation Targeting and Substitution Based on Synonymous Mutations from High-Throughput Immunoglobulin Sequencing Data , 2013, Front. Immunol..
[23] R. Cummings,et al. Molecular Basis of 9G4 B Cell Autoreactivity in Human Systemic Lupus Erythematosus , 2013, The Journal of Immunology.
[24] A. Vincent,et al. MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters , 2013, PloS one.
[25] I. Illa,et al. Myasthenia gravis and the neuromuscular junction , 2013, Current opinion in neurology.
[26] A. Marx,et al. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. , 2013, Autoimmunity reviews.
[27] J. Goldstein,et al. Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[28] Scott D Boyd,et al. Convergent antibody signatures in human dengue. , 2013, Cell host & microbe.
[29] D. Hafler,et al. Specific peripheral B cell tolerance defects in patients with multiple sclerosis. , 2013, The Journal of clinical investigation.
[30] Jamie K. Scott,et al. Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation. , 2013, American journal of human genetics.
[31] F. Zimprich,et al. Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society , 2012, Wiener klinische Wochenschrift.
[32] Steven H. Kleinstein,et al. Quantifying selection in high-throughput Immunoglobulin sequencing data sets , 2012, Nucleic acids research.
[33] A. Vincent,et al. Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects , 2012, Experimental Neurology.
[34] J. Verschuuren,et al. Long-lasting treatment effect of rituximab in MuSK myasthenia , 2012, Neurology.
[35] Stephen L. Hauser,et al. Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation , 2011, Proceedings of the National Academy of Sciences.
[36] David Kipling,et al. The Relationship between CD27 Negative and Positive B Cell Populations in Human Peripheral Blood , 2011, Front. Immun..
[37] G. Dranoff,et al. Ex vivo characterization and isolation of rare memory B cells with antigen tetramers. , 2011, Blood.
[38] J. Goldstein,et al. Response of patients with refractory myasthenia gravis to rituximab: a retrospective study , 2011, Therapeutic advances in neurological disorders.
[39] Y. Yamanashi,et al. Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis , 2011, Annals of neurology.
[40] Michal Barak,et al. Somatic hypermutation and antigen-driven selection of B cells are altered in autoimmune diseases. , 2010, Journal of autoimmunity.
[41] Robert C. Edgar,et al. Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..
[42] David Kipling,et al. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. , 2010, Blood.
[43] Jan Berka,et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire , 2009, Proceedings of the National Academy of Sciences.
[44] J. Bennett,et al. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis , 2009, Journal of Neuroimmunology.
[45] Hedda Wardemann,et al. B-cell tolerance checkpoints in health and autoimmunity. , 2008, Current opinion in immunology.
[46] J. Newsom-Davis,et al. The myasthenia gravis thymus: A rare source of human autoantibody-secreting plasma cells for testing potential therapeutics , 2008, Journal of Neuroimmunology.
[47] A. Vincent,et al. IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis† , 2008, Brain : a journal of neurology.
[48] F. Dekker,et al. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1 , 2008, Journal of Neuroimmunology.
[49] V. Pascual,et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[50] A. Marx,et al. Fewer thymic changes in MuSK antibody‐positive than in MuSK antibody‐negative MG , 2005, Annals of neurology.
[51] E. Meffre,et al. Impaired early B cell tolerance in patients with rheumatoid arthritis , 2005, The Journal of experimental medicine.
[52] R. Pelanda,et al. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens , 2004, Nature Immunology.
[53] M. Nussenzweig,et al. Surrogate Light Chain Expressing Human Peripheral B Cells Produce Self-reactive Antibodies , 2004, The Journal of experimental medicine.
[54] M. Nussenzweig,et al. Predominant Autoantibody Production by Early Human B Cell Precursors , 2003, Science.
[55] L. Phillips. The Epidemiology of Myasthenia Gravis , 2003, Neurologic clinics.
[56] A. Vincent,et al. Unravelling the pathogenesis of myasthenia gravis , 2002, Nature Reviews Immunology.
[57] H. Shiono,et al. Somatic Hypermutation and Selection of B Cells in Thymic Germinal Centers Responding to Acetylcholine Receptor in Myasthenia Gravis1 , 2001, The Journal of Immunology.
[58] Marie-Paule Lefranc,et al. Nomenclature of the Human Immunoglobulin Heavy (IGH) Genes , 2001, Experimental and Clinical Immunogenetics.
[59] A. Vincent,et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies , 2001, Nature Medicine.
[60] J. Xu,et al. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. , 2000, Immunity.
[61] A. Vincent,et al. Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. , 1997, International immunology.
[62] D. Burton,et al. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. , 1997, Journal of immunology.
[63] J. Bach,et al. Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor. , 1995, Molecular immunology.
[64] Y. Richard,et al. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis. , 1990, Journal of immunology.
[65] R. Hohlfeld,et al. Effector mechanisms in myasthenia gravis: End‐plate function after passive transfer of IgG, Fab, and F(ab′)2 hybrid molecules , 1986, Muscle & nerve.
[66] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[67] G. Scadding,et al. Acetylcholine receptor antibody synthesis by thymic lymphocytes , 1981, Neurology.
[68] A Ikai,et al. Thermostability and aliphatic index of globular proteins. , 1980, Journal of biochemistry.
[69] A. Engel,et al. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies , 1976, The Journal of experimental medicine.
[70] R. Grantham. Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.
[71] M. Hill. Diversity and Evenness: A Unifying Notation and Its Consequences , 1973 .
[72] J. M. Zimmerman,et al. The characterization of amino acid sequences in proteins by statistical methods. , 1968, Journal of theoretical biology.
[73] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[74] V. Giudicelli,et al. IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. , 2012, Methods in molecular biology.
[75] S. Gammeltoft,et al. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. , 1987, Clinical and experimental immunology.
[76] Dexter S. Moore,et al. Amino acid and peptide net charges: A simple calculational procedure , 1985 .
[77] A. Chao. Nonparametric estimation of the number of classes in a population , 1984 .